 | • レポートコード：MRC2-11QY13545 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は軟骨無形成症治療のグローバル市場について調査・分析したレポートです。種類別（RBM-007、TA-46、B-701、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別軟骨無形成症治療の競争状況、市場シェア ・世界の軟骨無形成症治療市場：種類別市場規模 2015年-2020年（RBM-007、TA-46、B-701、その他） ・世界の軟骨無形成症治療市場：種類別市場規模予測 2021年-2026年（RBM-007、TA-46、B-701、その他） ・世界の軟骨無形成症治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の軟骨無形成症治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の軟骨無形成症治療市場分析：米国、カナダ ・ヨーロッパの軟骨無形成症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの軟骨無形成症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の軟骨無形成症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの軟骨無形成症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Ascendis Pharma A/S、BioMarin Pharmaceutical Inc、Ribomic Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Achondroplasia Treatment Market
The global Achondroplasia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Achondroplasia Treatment Scope and Market Size
Achondroplasia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Achondroplasia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Ascendis Pharma A/S
BioMarin Pharmaceutical Inc
Ribomic Inc
…
Market segment by Type, the product can be split into
RBM-007
TA-46
B-701
Others
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Achondroplasia Treatment Revenue
1.4 Market by Type
1.4.1 Global Achondroplasia Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 RBM-007
1.4.3 TA-46
1.4.4 B-701
1.4.5 Others
1.5 Market by Application
1.5.1 Global Achondroplasia Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Achondroplasia Treatment Market Perspective (2015-2026)
2.2 Global Achondroplasia Treatment Growth Trends by Regions
2.2.1 Achondroplasia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Achondroplasia Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Achondroplasia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Achondroplasia Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Achondroplasia Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Achondroplasia Treatment Players by Market Size
3.1.1 Global Top Achondroplasia Treatment Players by Revenue (2015-2020)
3.1.2 Global Achondroplasia Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Achondroplasia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Achondroplasia Treatment Market Concentration Ratio
3.2.1 Global Achondroplasia Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Achondroplasia Treatment Revenue in 2019
3.3 Achondroplasia Treatment Key Players Head office and Area Served
3.4 Key Players Achondroplasia Treatment Product Solution and Service
3.5 Date of Enter into Achondroplasia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Achondroplasia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Achondroplasia Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Achondroplasia Treatment Market Size by Application (2015-2020)
5.2 Global Achondroplasia Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Achondroplasia Treatment Market Size (2015-2020)
6.2 Achondroplasia Treatment Key Players in North America (2019-2020)
6.3 North America Achondroplasia Treatment Market Size by Type (2015-2020)
6.4 North America Achondroplasia Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Achondroplasia Treatment Market Size (2015-2020)
7.2 Achondroplasia Treatment Key Players in Europe (2019-2020)
7.3 Europe Achondroplasia Treatment Market Size by Type (2015-2020)
7.4 Europe Achondroplasia Treatment Market Size by Application (2015-2020)
8 China
8.1 China Achondroplasia Treatment Market Size (2015-2020)
8.2 Achondroplasia Treatment Key Players in China (2019-2020)
8.3 China Achondroplasia Treatment Market Size by Type (2015-2020)
8.4 China Achondroplasia Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Achondroplasia Treatment Market Size (2015-2020)
9.2 Achondroplasia Treatment Key Players in Japan (2019-2020)
9.3 Japan Achondroplasia Treatment Market Size by Type (2015-2020)
9.4 Japan Achondroplasia Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Achondroplasia Treatment Market Size (2015-2020)
10.2 Achondroplasia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Achondroplasia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Achondroplasia Treatment Market Size by Application (2015-2020)
11 India
11.1 India Achondroplasia Treatment Market Size (2015-2020)
11.2 Achondroplasia Treatment Key Players in India (2019-2020)
11.3 India Achondroplasia Treatment Market Size by Type (2015-2020)
11.4 India Achondroplasia Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Achondroplasia Treatment Market Size (2015-2020)
12.2 Achondroplasia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Achondroplasia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Achondroplasia Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Ascendis Pharma A/S
13.1.1 Ascendis Pharma A/S Company Details
13.1.2 Ascendis Pharma A/S Business Overview
13.1.3 Ascendis Pharma A/S Achondroplasia Treatment Introduction
13.1.4 Ascendis Pharma A/S Revenue in Achondroplasia Treatment Business (2015-2020))
13.1.5 Ascendis Pharma A/S Recent Development
13.2 BioMarin Pharmaceutical Inc
13.2.1 BioMarin Pharmaceutical Inc Company Details
13.2.2 BioMarin Pharmaceutical Inc Business Overview
13.2.3 BioMarin Pharmaceutical Inc Achondroplasia Treatment Introduction
13.2.4 BioMarin Pharmaceutical Inc Revenue in Achondroplasia Treatment Business (2015-2020)
13.2.5 BioMarin Pharmaceutical Inc Recent Development
13.3 Ribomic Inc
13.3.1 Ribomic Inc Company Details
13.3.2 Ribomic Inc Business Overview
13.3.3 Ribomic Inc Achondroplasia Treatment Introduction
13.3.4 Ribomic Inc Revenue in Achondroplasia Treatment Business (2015-2020)
13.3.5 Ribomic Inc Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Achondroplasia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Achondroplasia Treatment Revenue
Table 3. Ranking of Global Top Achondroplasia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Achondroplasia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of RBM-007
Table 6. Key Players of TA-46
Table 7. Key Players of B-701
Table 8. Key Players of Others
Table 9. Global Achondroplasia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Achondroplasia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Achondroplasia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Achondroplasia Treatment Market Share by Regions (2015-2020)
Table 13. Global Achondroplasia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Achondroplasia Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Achondroplasia Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Achondroplasia Treatment Players
Table 20. Global Achondroplasia Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Achondroplasia Treatment Market Share by Players (2015-2020)
Table 22. Global Top Achondroplasia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Achondroplasia Treatment as of 2019)
Table 23. Global Achondroplasia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Achondroplasia Treatment Product Solution and Service
Table 26. Date of Enter into Achondroplasia Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Achondroplasia Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Achondroplasia Treatment Market Size Share by Type (2015-2020)
Table 30. Global Achondroplasia Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Achondroplasia Treatment Market Size Share by Application (2015-2020)
Table 32. Global Achondroplasia Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Achondroplasia Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Achondroplasia Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Achondroplasia Treatment Market Share (2019-2020)
Table 36. North America Achondroplasia Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Achondroplasia Treatment Market Share by Type (2015-2020)
Table 38. North America Achondroplasia Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Achondroplasia Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Achondroplasia Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Achondroplasia Treatment Market Share (2019-2020)
Table 42. Europe Achondroplasia Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Achondroplasia Treatment Market Share by Type (2015-2020)
Table 44. Europe Achondroplasia Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Achondroplasia Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Achondroplasia Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Achondroplasia Treatment Market Share (2019-2020)
Table 48. China Achondroplasia Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Achondroplasia Treatment Market Share by Type (2015-2020)
Table 50. China Achondroplasia Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Achondroplasia Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Achondroplasia Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Achondroplasia Treatment Market Share (2019-2020)
Table 54. Japan Achondroplasia Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Achondroplasia Treatment Market Share by Type (2015-2020)
Table 56. Japan Achondroplasia Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Achondroplasia Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Achondroplasia Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Achondroplasia Treatment Market Share (2019-2020)
Table 60. Southeast Asia Achondroplasia Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Achondroplasia Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Achondroplasia Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Achondroplasia Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Achondroplasia Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Achondroplasia Treatment Market Share (2019-2020)
Table 66. India Achondroplasia Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Achondroplasia Treatment Market Share by Type (2015-2020)
Table 68. India Achondroplasia Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Achondroplasia Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Achondroplasia Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Achondroplasia Treatment Market Share (2019-2020)
Table 72. Central & South America Achondroplasia Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Achondroplasia Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Achondroplasia Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Achondroplasia Treatment Market Share by Application (2015-2020)
Table 76. Ascendis Pharma A/S Company Details
Table 77. Ascendis Pharma A/S Business Overview
Table 78. Ascendis Pharma A/S Product
Table 79. Ascendis Pharma A/S Revenue in Achondroplasia Treatment Business (2015-2020) (Million US$)
Table 80. Ascendis Pharma A/S Recent Development
Table 81. BioMarin Pharmaceutical Inc Company Details
Table 82. BioMarin Pharmaceutical Inc Business Overview
Table 83. BioMarin Pharmaceutical Inc Product
Table 84. BioMarin Pharmaceutical Inc Revenue in Achondroplasia Treatment Business (2015-2020) (Million US$)
Table 85. BioMarin Pharmaceutical Inc Recent Development
Table 86. Ribomic Inc Company Details
Table 87. Ribomic Inc Business Overview
Table 88. Ribomic Inc Product
Table 89. Ribomic Inc Revenue in Achondroplasia Treatment Business (2015-2020) (Million US$)
Table 90. Ribomic Inc Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Achondroplasia Treatment Market Share by Type: 2020 VS 2026
Figure 2. RBM-007 Features
Figure 3. TA-46 Features
Figure 4. B-701 Features
Figure 5. Others Features
Figure 6. Global Achondroplasia Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Achondroplasia Treatment Report Years Considered
Figure 11. Global Achondroplasia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Achondroplasia Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Achondroplasia Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Achondroplasia Treatment Market Share by Players in 2019
Figure 16. Global Top Achondroplasia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Achondroplasia Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Achondroplasia Treatment Revenue in 2019
Figure 18. North America Achondroplasia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Achondroplasia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Achondroplasia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Achondroplasia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Achondroplasia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Achondroplasia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Achondroplasia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
統合失調感情障害治療の世界市場（～2026年） Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders. The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. Market Analysis and Insights: Global Schizoaffective Disorders Treatment Market Th…- 巨細胞性動脈炎治療の世界市場（～2026年） Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin …
- 酒さ治療の世界市場（～2026年） Rosacea is a chronic skin disease that generally affects the white population. Rising demand from European region is a major driver for the growth of the Rosacea Treatment market. Market Analysis and Insights: Global Rosacea Treatment Market The global Rosacea Treatment market size is projected to r…
- 気管支拡張症治療の世界市場（～2026年） Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in seri…
- グロボイド細胞白質ジストロフィー（GLD）治療の世界市場（～2026年） Market Analysis and Insights: Global Globoid Cell Leukodystrophy Treatment Market The global Globoid Cell Leukodystrophy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Globoid Cell Leukodystrophy Treatment S…